Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

1,105

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions
Stroke, Acute
Interventions
DRUG

Nerinetide (NA-1), 2.6 mg/kg

Single intravenous infusion of nerinetide over 10 ± 1 minutes

DRUG

Placebo

Placebo Comparator: Placebo

Trial Locations (50)

11220

NYU Lutheran Medical Center, Brooklyn

15213

UPMC Presbyterian, Pittsburgh

17176

Karolinksa Institutet, Stockholm

19001

Abington Memorial Hospital, Philadelphia

27103

Novant Health Forsyth Medical Center, Winston-Salem

30060

WellStar Health Systems, Marietta

30303

Grady Memorial Hospital, Atlanta

32207

Baptist Health Medical Center, Jacksonville

37075

University Medical Center Goettingen, Göttingen

37403

Chattanooga Center for Neurologic Research, Chattanooga

43214

Riverside Radiology, Columbus

60612

Rush University Medical Center, Chicago

64111

Saint Luke's Hospital of Kansas City, Kansas City

69120

Neurologische Klinik, Universität Heidelberg, Heidelberg

78550

Valley Baptist Medical Center, Harlingen

80110

Swedish Medical Center, Englewood

90095

Ronald Reagan UCLA Medical Center, Los Angeles

90503

Providence Little Company of Mary Medical Center Torrance, Torrance

94114

California Pacific Medical Center - Davies Campus, San Francisco

98122

Swedish Medical Center- Cherry Hill Campus, Seattle

06510

Yale New Haven Hospital, New Haven

01655

University of Massachusetts Medical School, Worcester

02903

Rhode Island Hospital, Providence

Unknown

Royal Adelaide Hospital, Adelaide

Royal Melbourne Hospital, Parkville

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Beaumont Hospital, Dublin

Mater Hospital, Dublin

Dongsan Medical Centre, Daegu

Inha University Hospital, Incheon

Samsung Medical Center, Seoul

Yonsei Univ, Severence, Seoul

Skåne University Hospital, Lund

Royal Victoria Hospital, Belfast

T2N2T9

University of Calgary - Foothills Medical Centre, Calgary

T6G 2B7

University of Alberta Hospital, Edmonton

V5Z 1M9

Vancouver Stroke Program Research Office/ Vancouver General Hosptial, Vancouver

B3H 3A7

Queen Elizabeth II Health Science Centre, Halifax

L8L 2X2

Hamilton General Hospital, Hamilton

N6A 5A5

London Health Sciences Centre- University Hospital, London

K1Y 4E9

The Ottawa Hospital, Ottawa

M4N 3M5

Sunnybrook Health Centre, Toronto

M5B 1W8

St Michael's Hospital, Toronto

M5T 2S8

University Health Network - Toronto Western Hospital, Toronto

H2L 4M1

CHUM Hopital Notre-Dame, Montreal

H3A1A1

Montreal Neurological Institute and Hospital, Montreal

G1J 1Z4

CHU de Quebec- Universite Laval- Hopital de l'Enfant-Jesus, Québec

S7N 0W8

Royal University Hospital, Saskatoon

01307

Universitätsklinikum Carl Gustav Carus Dresdner Neurovaskulares Centrum, Dresden

D - 45131

Klinik für Radiologie und Neuroradiologie, Essen

All Listed Sponsors
collaborator

University of Calgary

OTHER

lead

NoNO Inc.

INDUSTRY

NCT02930018 - Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke | Biotech Hunter | Biotech Hunter